SINGAPORE, June 28 — As of May 31, there have been four reports of"non-serious adverse events" in the two weeks following the roll-out of the Nuvaxovid Covid-19 vaccine in Singapore, the Health Sciences Authority said yesterday .“These are largely consistent with what was reported in the clinical studies and are known adverse effects associated with vaccines,” HSA said in its 12th vaccine safety report, which covers the period from December 30, 2020, to May 31 this year.
An adverse event for vaccination is any undesirable medical condition that occurs after taking the vaccine and it has to be reported by healthcare providers to HSA. It is classified as serious when the event results in conditions such as hospitalisation, a significant reduction in functioning level, a life-threatening illness or death.
The authority also gave an update on the other Covid-19 vaccines in use, saying that incidence rates of adverse events of interest with messenger ribonucleic acid vaccines have stabilised, with no new findings since the last update in February.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: theSundaily - 🏆 25. / 51 Read more »
Source: UMonline - 🏆 27. / 51 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »
Source: staronline - 🏆 4. / 75 Read more »
Source: UMonline - 🏆 27. / 51 Read more »
Source: UMonline - 🏆 27. / 51 Read more »